Skip to main content
Medfolio
Kidney Function · Glossary

eGFR

Estimated Glomerular Filtration Rate

हिंदी · ईजीएफआर / गुर्दे की फिल्ट्रेशन दर

What eGFR estimates about kidney filtration, how it is worked out from creatinine, what the stages mean, and when to talk to your doctor about a low result.

This page is general educational content. It describes what eGFR measures and how doctors generally interpret it. It does not interpret your individual result. Always discuss your reports with a qualified medical professional.

Reviewed by the Medfolio editorial team
Written for an Indian audience against current ICMR, WHO, and NIH guidance · Last updated 27 May 2026
In your home language — हिंदी · తెలుగు · தமிழ் · मराठी · ਪੰਜਾਬੀ translations coming

Also seen on reports as: GFR (estimated), Estimated GFR, eGFR CKD-EPI, eGFR MDRD

What is eGFR?

eGFR (Estimated Glomerular Filtration Rate) is a calculated number that estimates how much blood the kidneys are filtering each minute. It is not measured directly from a separate test — it is calculated from the blood creatinine level along with age and sex (and historically sometimes race), using one of several established formulas (CKD-EPI is the most common today; MDRD was widely used previously).

Because eGFR is calculated rather than measured, it depends entirely on the inputs being accurate. The biggest source of variation is muscle mass: people with very high or very low muscle mass do not fit the assumptions the formula was built on, and the eGFR estimate becomes less reliable for them.

Most NABL-accredited Indian labs report eGFR alongside creatinine automatically. The value is expressed in millilitres per minute per 1.73 m² of body surface area (mL/min/1.73 m²) — a normal adult is roughly 90 or higher.

Why doctors order it

eGFR is not separately ordered — it is calculated from the same creatinine result and appears on the lab report alongside it. Almost every routine blood-test panel in India that includes creatinine also reports eGFR.

eGFR is the main number doctors use to stage chronic kidney disease (CKD) and to decide how aggressively to investigate or treat. The CKD stages (1 through 5) are defined largely by eGFR ranges, alongside urine findings.

It is also used to decide whether common medications and contrast dyes are safe to use at standard doses, or whether they need dose adjustment or avoidance — particularly for many antibiotics, anti-diabetic medications, anti-hypertensives, and chemotherapy.

What the result means

An eGFR of 90 or above is generally considered normal kidney filtering — though this alone does not rule out kidney disease, particularly if there is protein in the urine, structural abnormalities on ultrasound, or other markers of kidney injury. An eGFR between 60 and 89 may be normal for age in some people; it is considered mildly decreased and needs context to interpret.

Persistently low eGFR (below 60 for three months or more) is part of the definition of chronic kidney disease. The CKD stages step down from there — stage 3 (eGFR 30–59), stage 4 (15–29), and stage 5 (below 15, often called end-stage kidney disease).

eGFR can change acutely — for example, with severe dehydration, with medications that affect kidney blood flow, with very high blood pressure, or with sudden urinary obstruction. Acute changes need different work-up from chronic changes; doctors interpret eGFR alongside the trend, urine tests, and clinical picture.

Reference range

Values in mL/min/1.73 m²

Stage G1 — normal or high
eGFR ≥90 — kidney disease only if urine or imaging abnormalities present
Stage G2 — mildly decreased
eGFR 60–89 — may be normal for age; interpret with urine and clinical context
Stage G3a — mildly to moderately decreased
eGFR 45–59 — formal CKD; needs follow-up
Stage G3b — moderately to severely decreased
eGFR 30–44
Stage G4 — severely decreased
eGFR 15–29 — pre-dialysis planning may be needed
Stage G5 — kidney failure
eGFR <15 — usually requires dialysis or transplant planning

eGFR formulas (CKD-EPI / MDRD) were largely developed and validated in Western populations. Indian adults often have lower muscle mass than Western reference populations, which means these formulas can overestimate true kidney function in some Indians. There is no widely-adopted Indian-specific eGFR equation in routine use; doctors interpret eGFR in clinical context alongside creatinine, urine tests, and (in some situations) cystatin-C-based eGFR.

Common factors that affect the result

Indian-specific interpretation matters. The CKD-EPI and MDRD equations were developed and validated mainly in Western populations with different average muscle mass. Indian adults — particularly women, the elderly, and people with chronic illness — often have lower muscle mass than those reference populations. This can cause the formula to overestimate true kidney function in some Indians, meaning a 'normal' eGFR can sometimes hide an early kidney problem.

Because eGFR is calculated from creatinine, everything that affects creatinine also affects eGFR. High muscle mass, intense recent exercise, creatine supplements, and high-protein diets nudge creatinine up — and eGFR down — without true kidney injury. Low muscle mass from age, illness, or weight loss nudges creatinine down and eGFR up, without truly better kidney function.

Acute factors that change blood flow to the kidney — severe dehydration, heart failure, low blood pressure, urinary obstruction — drop eGFR temporarily. These pre-renal drops usually recover once the underlying problem is corrected. Some doctors use cystatin-C-based eGFR in tricky cases (very high or very low muscle mass, or where Indian-specific concerns apply) — cystatin C is less dependent on muscle mass.

When to talk to your doctor

  • Your eGFR has dropped below 60 mL/min/1.73 m² for the first time, particularly if a previous result was higher.
  • Your eGFR is between 60 and 89 with protein in the urine, structural abnormalities on ultrasound, diabetes, or hypertension — these combinations meet the CKD definition even with eGFR not yet 'low'.
  • Your eGFR has dropped sharply over weeks to months, regardless of where it sits in the range — a rapid drop usually needs evaluation for acute kidney injury.
  • You are starting a medication or contrast dye and your eGFR is being checked to confirm safe dosing — common examples include metformin, certain antibiotics, anti-cancer drugs, and CT-scan contrast.
  • You have diabetes, hypertension, recurrent kidney stones, or a family history of kidney disease and want to discuss whether your eGFR trend over time is moving in a concerning direction.

Related tests

Sources

  • Indian Society of Nephrology — CKD Clinical Practice Guidelines — Indian Society of Nephrology
  • ICMR CKD Screening Guidelines — Indian Council of Medical Research
  • KDIGO 2024 Clinical Practice Guidelines for CKD — Kidney Disease: Improving Global Outcomes
  • AIIMS Nephrology Clinical Protocols — All India Institute of Medical Sciences

See our medical disclaimer for what this content is and is not.

Frequently asked questions

No — eGFR is calculated, not measured. The lab uses your creatinine, age, and sex to calculate eGFR using a formula (most commonly CKD-EPI). You do not need a separate blood draw for eGFR; it appears automatically alongside creatinine on most Indian lab reports.

It is widely used in India but has known limitations. The formulas (CKD-EPI, MDRD) were largely developed and validated in Western populations with different average muscle mass. Indian adults often have lower muscle mass, which can cause the formula to overestimate true kidney function in some people — meaning a 'normal' eGFR can sometimes mask early kidney involvement. There is no widely-adopted Indian-specific formula in routine clinical use yet; doctors interpret eGFR alongside creatinine, urine tests, and clinical context. In tricky cases, some doctors order cystatin-C-based eGFR, which is less affected by muscle mass.

Not necessarily. An eGFR of 60–89 (Stage G2) is considered mildly decreased — it may be normal for your age, and on its own does not meet the definition of chronic kidney disease. CKD at this stage requires either persistence over three months along with other markers of kidney damage (protein in urine, abnormal imaging, electrolyte changes) or a sustained eGFR below 60. Your doctor reads the value alongside urine tests and the clinical picture.

Acute drops in eGFR — from dehydration, heart failure, urinary obstruction, or some medications — often recover once the underlying problem is corrected. Chronic kidney disease tends to be stable or slowly progressive; treating the underlying causes (blood sugar, blood pressure, avoiding nephrotoxic medications) can slow further loss. Significant 'recovery' from chronic stages is less common, though stabilisation is a meaningful and realistic goal.

Avoid intense exercise in the 24 hours before the test (can raise creatinine and lower eGFR), pause creatine supplements if you take them (check with your doctor first), stay normally hydrated (not dehydrated, not over-loaded), and follow whatever fasting instruction the lab gives for the broader panel. Test under similar conditions each time so the trend is meaningful.

Track your eGFR over the years.

Get Medfolio and see how your eGFR is moving — visit by visit, lab by lab.

Coming soon to Google Play. Coming soon on the App Store.